LIGAND PHARMACEUTICALS INCORPORATED Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) of $9.79 million as of 2012-03-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent · last filed 2012-11-14
- 2012-03-31: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $9.79M.
- 2011-12-31: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $10.42M.
- 2010-12-31: Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) $700.00K.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value, Noncurrent (Deprecated 2013-01-31) |
|---|---|
| 2012-03-31 | $9.79M 10-Q/A · filed 2012-11-14 |
| 2011-12-31 | $10.42M 10-Q/A · filed 2012-11-14 |
| 2010-12-31 | $700.00K 10-K/A · filed 2012-11-14 |